QuPath: Open source software for digital pathology image analysis
Peter Bankhead,Maurice B Loughrey,Maurice B Loughrey,José A Fernández,Yvonne Dombrowski,Darragh G. McArt,Philip D Dunne,Stephen McQuaid,Stephen McQuaid,Ronan T. Gray,Liam J. Murray,Helen G. Coleman,Jacqueline A James,Jacqueline A James,Manuel Salto-Tellez,Manuel Salto-Tellez,Peter W. Hamilton +16 more
TL;DR: QuPath provides researchers with powerful batch-processing and scripting functionality, and an extensible platform with which to develop and share new algorithms to analyze complex tissue images, making it suitable for a wide range of additional image analysis applications across biomedical research.
read more
Abstract: QuPath is new bioimage analysis software designed to meet the growing need for a user-friendly, extensible, open-source solution for digital pathology and whole slide image analysis. In addition to offering a comprehensive panel of tumor identification and high-throughput biomarker evaluation tools, QuPath provides researchers with powerful batch-processing and scripting functionality, and an extensible platform with which to develop and share new algorithms to analyze complex tissue images. Furthermore, QuPath’s flexible design makes it suitable for a wide range of additional image analysis applications across biomedical research.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
CellProfiler 4: Improvements in Speed, Utility and Usability
David R. Stirling,Madison J. Swain-Bowden,Alice Lucas,Anne E. Carpenter,Beth A. Cimini,Allen Goodman +5 more
TL;DR: The CellProfiler 4 as mentioned in this paper is a new version of this software which has been ported to the Python 3 language based on user feedback, which has made several user interface refinements to improve the usability of the software.
Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer's Disease.
Wei Ting Chen,Wei Ting Chen,Ashley Lu,Ashley Lu,Katleen Craessaerts,Katleen Craessaerts,Benjamin Pavie,Carlo Sala Frigerio,Carlo Sala Frigerio,Carlo Sala Frigerio,Nikky Corthout,Xiaoyan Qian,Jana Lalakova,Malte Kühnemund,Iryna Voytyuk,Iryna Voytyuk,Leen Wolfs,Leen Wolfs,Renzo Mancuso,Renzo Mancuso,Evgenia Salta,Evgenia Salta,Sriram Balusu,Sriram Balusu,An Snellinx,An Snellinx,Sebastian Munck,Aleksandra Jurek,José Fernández Navarro,Takaomi C. Saido,Inge Huitinga,Inge Huitinga,Joakim Lundeberg,Mark Fiers,Mark Fiers,Mark Fiers,Bart De Strooper,Bart De Strooper,Bart De Strooper +38 more
TL;DR: Genome-wide spatial transcriptomics analysis provides an unprecedented approach to untangle the dysregulated cellular network in the vicinity of pathogenic hallmarks of AD and other brain diseases.
723
Altered human oligodendrocyte heterogeneity in multiple sclerosis
Sarah Jäkel,Eneritz Agirre,Ana Mendanha Falcão,David van Bruggen,Ka Wai Lee,Irene Knuesel,Dheeraj Malhotra,Charles ffrench-Constant,Anna Williams,Gonçalo Castelo-Branco +9 more
TL;DR: Single-nucleus RNA sequencing analysis identifies different subclusters of oligodendroglia in white matter from individuals with multiple sclerosis compared with controls, and these differences may be important for understanding disease progression and developing therapeutic approaches.
The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression
TL;DR: The Warburg effect is the central contributor to the cancer progression machinery and synergistically favors tumor progression and resistance to certain antitumor therapies, and compromises antitumors immunity.
702
Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy.
Jerome Martin,Christie Chang,Gilles Boschetti,Ryan C. Ungaro,Mamta Giri,John A. Grout,Kyle Gettler,Ling-Shiang Chuang,Shikha Nayar,Alexander Greenstein,Marla Dubinsky,Laura Walker,Andrew Leader,Jay S. Fine,Charles E. Whitehurst,M. Lamine Mbow,Subra Kugathasan,Lee A. Denson,Jeffrey S. Hyams,Joshua R. Friedman,Prerak T. Desai,Huaibin M. Ko,Ilaria Laface,Guray Akturk,Eric E. Schadt,Hélène Salmon,Sacha Gnjatic,Adeeb Rahman,Miriam Merad,Judy H. Cho,Ephraim Kenigsberg +30 more
TL;DR: Analysis of ligand-receptor interaction pairs identified a distinct network connectivity that likely drives the GIMATS module, which was present in a subset of patients in four independent iCD cohorts and correlated with failure to achieve durable corticosteroid-free remission upon anti-TNF therapy.
684
References
Random Forests
Leo Breiman
- 01 Oct 2001
TL;DR: Internal estimates monitor error, strength, and correlation and these are used to show the response to increasing the number of features used in the forest, and are also applicable to regression.
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin,Ignacio Arganda-Carreras,Erwin Frise,Verena Kaynig,Mark Longair,Tobias Pietzsch,Stephan Preibisch,Curtis Rueden,Stephan Saalfeld,Benjamin Schmid,Jean-Yves Tinevez,Daniel J. White,Volker Hartenstein,Kevin W. Eliceiri,Pavel Tomancak,Albert Cardona +15 more
TL;DR: Fiji is a distribution of the popular open-source software ImageJ focused on biological-image analysis that facilitates the transformation of new algorithms into ImageJ plugins that can be shared with end users through an integrated update system.
NIH Image to ImageJ: 25 years of image analysis
TL;DR: The origins, challenges and solutions of NIH Image and ImageJ software are discussed, and how their history can serve to advise and inform other software projects.
Systematic Review: Process of Forming Academic Service Partnerships to Reform Clinical Education
TL;DR: This study’s findings can provide practical guidelines to steer partnership programs within the academic and clinical bodies, with the aim of providing a collaborative partnership approach to clinical education.
42.9K
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Andreas D. Hartkopf,Florin-Andrei Taran,Markus Wallwiener,Christina B. Walter,Bernhard K. Krämer,Eva-Maria Grischke,Sara Y. Brucker +6 more
TL;DR: This review summarizes the clinical efficacy, perspectives, and future challenges of using PD-1/PD-L1-directed antibodies in the treatment of breast cancer.